Pay in 4 interest-free payments of $88.75 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
1135-99-5 (unlabelled)
74875-96-0
Download: Application Note (PDF) - PFAS analysis according to FDA method C-010
IV-STOCK-13-125ML
EC UHPLC column (analytical), NUCLEODUR PolarTec, 1.8 µm, 30x3 mm 1000 ppm 1135-99-5 (unlabelled)Based on high purity NUCLEODUR silica gel, a polar group was embedded in a hydrophobic C18 modification. As a result, this HPLC phase shows steric and an increased polar selectivity. This HPLC phase shows a good performance under high aqueous conditions. It is a hydrophobic phase with pronounced hydrophilic properties. Separation mechanism based on hydrophobic (van der Waals) and polar interactions. Suitable for LC MS due to low bleeding
US$ 29.00
US$ 193.78
US$ 130.00
US$ 148.31
US$ 122.81
US$ 173.37
US$ 148.31
US$ 107.08
US$ 141.51
US$ 126.21